FDA Will Reverse Rejection of Third Rare-Disease Drug, Regenxbio Says
Technology

FDA Will Reverse Rejection of Third Rare-Disease Drug, Regenxbio Says

Economy World



FDA Will Reverse Rejection of Third Rare-Disease Drug, Regenxbio Says
The company plans to refile its application for its gene therapy for a fatal brain disease after the FDA dropped demands to give a placebo to some study subjects.

Leave a Reply

Your email address will not be published. Required fields are marked *